DUBLIN–(BUSINESS WIRE)–The “Dry Eye Medication Global Market Opportunities and Strategies to 2030: COVID 19 Impact and Recovery” report has been added to ResearchAndMarkets.com’s offering. This report provides the strategists, marketers and senior ma…
LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus today announced that it has received a new Grant Award from the FDA to enhance the ocular (OCAT) model in its GastroPlus software.
Pooled study data showed satralizumab for the treatment of neuromyelitis optica spectrum disorder was well tolerated as monotherapy or in combination with immunosuppressive therapy, according to a press release.The pooled data from the double-masked pe…
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics Subsidiary Orpheris Announces FDA Agreement to Initiate Phase 2 Study Evaluating OP-101 in Severe COVID-19 Patients
The COVID-19 pandemic has had significant global consequences, with healthcare systems stretched to their limits, a growing death toll, and economic devastation as economies came grinding to a halt. The pandemic and its aftereffects will be with us for some time to come, but this isn’t the first pandemic humanity has weathered, and it won&rsq (Read more...)
Both IOP and medication use were reduced and glaucoma did not progress in the majority of patients in a study looking at 5-year visual field and OCT outcomes after iStent implantation in a real-world clinical setting.“The iStent was able to stabilize v…